Literature DB >> 6190010

rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells.

R H Silverman, J J Skehel, T C James, D H Wreschner, I M Kerr.   

Abstract

In cell-free systems, 2-5A [ppp(A2'p)nA, n = 2 to greater than or equal to 4] activates a latent endoribonuclease, the 2-5A-dependent RNase, which cleaves rRNA in intact ribosomes into discrete and characteristic products (D. H. Wreschner et al., Nucleic Acids Res. 9:1571-1581, 1981). Here we present Northern blots which have identified the 18S or 28S origins of the cleaved products from rRNA. In addition, identical 3' termini were observed for fragments of 18S rRNA from a HeLa cell-free system incubated with 2-5A and from interferon-treated, encephalomyocarditis virus-infected HeLa cells. The previous assumption of identity of such fragments was based only on comigration on electrophoresis in agarose gels. We conclude that appropriate patterns of cleavage found in RNA isolated from intact cells are an indicator of prior 2-5A-dependent RNase activity. The assay of rRNA cleavage is relatively convenient and unambiguous. Accordingly, in the search for situations in which the 2-5A system may be active, it provides a useful alternative to the direct assay of 2-5A.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190010      PMCID: PMC256583     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A.

Authors:  C Baglioni; M A Minks; P A Maroney
Journal:  Nature       Date:  1978-06-22       Impact factor: 49.962

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

4.  Simple method for the isolation of encephalomyocarditis virus ribonucleic acid.

Authors:  I M Kerr; E M Martin
Journal:  J Virol       Date:  1972-03       Impact factor: 5.103

5.  Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation.

Authors:  L Ratner; R C Wiegand; P J Farrell; G C Sen; B Cabrer; P Lengyel
Journal:  Biochem Biophys Res Commun       Date:  1978-04-14       Impact factor: 3.575

6.  3'-terminal labelling of RNA with T4 RNA ligase.

Authors:  T E England; O C Uhlenbeck
Journal:  Nature       Date:  1978-10-12       Impact factor: 49.962

7.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.

Authors:  M J Clemens; B R Williams
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

9.  Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts.

Authors:  J J Skehel; A J Hay
Journal:  Nucleic Acids Res       Date:  1978-04       Impact factor: 16.971

10.  Mapping adenines, guanines, and pyrimidines in RNA.

Authors:  H Donis-Keller; A M Maxam; W Gilbert
Journal:  Nucleic Acids Res       Date:  1977-08       Impact factor: 16.971

View more
  60 in total

1.  Basis for regulated RNA cleavage by functional analysis of RNase L and Ire1p.

Authors:  B Dong; M Niwa; P Walter; R H Silverman
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

Review 2.  New insights into the role of RNase L in innate immunity.

Authors:  Arindam Chakrabarti; Babal Kant Jha; Robert H Silverman
Journal:  J Interferon Cytokine Res       Date:  2010-12-29       Impact factor: 2.607

3.  Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.

Authors:  Liliana Sánchez-Tacuba; Margarito Rojas; Carlos F Arias; Susana López
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

Review 4.  A scientific journey through the 2-5A/RNase L system.

Authors:  Robert H Silverman
Journal:  Cytokine Growth Factor Rev       Date:  2007-07-27       Impact factor: 7.638

Review 5.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

6.  RNase L triggers autophagy in response to viral infections.

Authors:  Arindam Chakrabarti; Prabar Kumar Ghosh; Shuvojit Banerjee; Christina Gaughan; Robert H Silverman
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

7.  Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.

Authors:  A Zhou; J Paranjape; T L Brown; H Nie; S Naik; B Dong; A Chang; B Trapp; R Fairchild; C Colmenares; R H Silverman
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

8.  La Crosse virus infection of mammalian cells induces mRNA instability.

Authors:  R Raju; D Kolakofsky
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

9.  RNase L activates the NLRP3 inflammasome during viral infections.

Authors:  Arindam Chakrabarti; Shuvojit Banerjee; Luigi Franchi; Yueh-Ming Loo; Michael Gale; Gabriel Núñez; Robert H Silverman
Journal:  Cell Host Microbe       Date:  2015-03-26       Impact factor: 21.023

10.  Poxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responses.

Authors:  Shin-Wu Liu; George C Katsafanas; Ruikang Liu; Linda S Wyatt; Bernard Moss
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.